Ca Regulation of Ca Channels
Ca 通道的 Ca 调节
基本信息
- 批准号:7265541
- 负责人:
- 金额:$ 34.85万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-07-01 至 2012-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAffinityAvidityBindingBinding SitesBiologicalC-terminalCalmodulinCardiacComplexDiffusionDrug CompoundingEngineeringEnvironmentFamilyGleanGrantIndividualKineticsLobeMeasurementMediatingModificationN-terminalNeuronsOperative Surgical ProceduresPainPatternPhasePsychotic DisordersRangeRegulationResearchSignal TransductionSignaling MoleculeSourceSurfaceSystemTestingTherapeuticTotal Internal Reflection Fluorescentbasedesigninsightnanometernext generationnovelpreferenceresearch studysensortheoriesvoltage
项目摘要
DESCRIPTION (provided by applicant): Over the past grant cycle, general rules for calmodulin (CaM) regulation of the family of Ca channels were discerned. CaM has two lobes, each with two Ca2+ binding sites. A first general aspect was that each lobe can autonomously trigger a form of channel regulation. Secondly, whenever the C-terminal lobe of CaM (C-lobe) triggers channel regulation, there is preferential responsiveness to local Ca2+ signals. Conversely, wherever the N-terminal lobe (N-lobe) initiates regulation, there is selectivity for global Ca2+ signals. Thirdly, there is reason to expect that this rule of operation generalizes beyond Ca channels, to many complexes in which CaM is preassociated with target molecules. Because CaM regulation of Ca channels (and other signaling molecules) is crucial for normal neuroprocessing, and likely important for therapeutics relating to pain, psychosis, and cardiac arrhythmogenesis, answering how these general rules occur is the overarching thrust for the next cycle of research. Three aims will address this overall theme. 1. To develop and perform elementary tests of a kinetic Ca2+ decoding mechanism for the CaM/Ca channel complex. This aim formulates a 'kinetic Ca2+ decoding' theory of how the CaM decoding occurs, and devises novel Voltage-block' experiments to enable elementary tests of this theory. 2. To engineer the local/global Ca2+ preference of CaM/Ca channel regulation, as a higher-order test of the kinetic Ca2+ decoding theory, and as means to glean design principles for developing novel channel modulators. A principal prediction of the kinetic Ca2+ decoding theory is that the local/global Ca2+ preference of channel regulation reflects competition between channel affinities for the Ca2+-bound and Ca2+-free forms of a lobe of CaM. Aim 2 will alter these affinities and check for the predicted changes in Ca2+ preference. Aim 2 will also explore whether these modifications can inform the design of drug compounds that modulate channel regulation in new ways. 3. To experimentally determine Ca2+ concentrations and diffusion within the nanometers of the Ca channel. Crucial to the next phase of progress is the direct measurements of local and global Ca2+ concentration signals, and Ca2+ diffusion, in the actual channel 'nanodomain' environment. Fusions of a genetically-encoded Ca2+ sensor (TNL-15) to channels, combined with TIRF microscopy promise to reveal these long sought-after entities. These aims promise bold progress, with basic and applied ramifications.
描述(由申请人提供):在过去的赠款周期中,CA渠道家族的钙调蛋白(CAM)调节的一般规则被辨别。 CAM有两个裂片,每个裂片都有两个Ca2+结合位点。第一个一般方面是,每个叶可以自主触发一种通道调节的形式。其次,每当CAM(C-LOBE)的C末端叶触发通道调节时,对局部CA2+信号的响应性就会优先。相反,无论N末端叶(N-LOBE)启动调节,全局CA2+信号都有选择性。第三,有理由期望这种操作规则将CA通道超出CA通道超出CAM与目标分子相关的许多复合物。因为CA通道(和其他信号分子)的CAM调节对于正常的神经化学方法至关重要,并且对于与疼痛,精神病和心脏心律失常发生有关的治疗剂可能很重要,因此回答这些通用规则是如何发生的,这是下一个研究周期的总体推力。三个目标将解决这个总体主题。 1。开发和执行针对CAM/CA通道复合物的动力学CA2+解码机理的基本测试。这个目标为凸轮解码的发生方式提出了“动力学CA2+解码”理论,并设计了新型的电压块“实验,以实现该理论的基本检验。 2。为了设计CAM/CA通道调节的局部/全局CA2+偏好,作为动力学CA2+解码理论的高阶测试,以及用于开发新型通道调节剂的设计原理的手段。动力学CA2+解码理论的主要预测是,通道调节的局部/全局CA2+偏好反映了CA2+结合的通道亲和力之间的竞争与CAM叶的无用形式。 AIM 2将改变这些亲和力,并检查CA2+偏好的预测变化。 AIM 2还将探索这些修饰是否可以为以新方式调节通道调节的药物化合物的设计提供信息。 3。通过实验确定Ca通道纳米内的Ca2+浓度和扩散。对于下一阶段的进步至关重要的是在实际的“纳米域”环境中直接测量局部和全局Ca2+浓度信号以及Ca2+扩散。遗传编码的Ca2+传感器(TNL-15)的融合与通道的融合,结合TIRF显微镜有望揭示这些长期追求的实体。这些目的有望大胆的进步,并具有基本和应用的后果。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID T YUE其他文献
DAVID T YUE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID T YUE', 18)}}的其他基金
Chemical biological dissection of Ca2+ entry through Ca2+ channels
Ca2+通过Ca2+通道进入的化学生物学解剖
- 批准号:
8609908 - 财政年份:2013
- 资助金额:
$ 34.85万 - 项目类别:
相似国自然基金
基于计算生物学技术小分子农兽药残留物驼源单域抗体虚拟筛选与亲和力成熟 -以内蒙古阿拉善双峰驼为例
- 批准号:32360190
- 批准年份:2023
- 资助金额:34 万元
- 项目类别:地区科学基金项目
基于胞内蛋白亲和力标记策略进行新型抗类风湿性关节炎的选择性OGG1小分子抑制剂的发现
- 批准号:82304698
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于多尺度表征和跨模态语义匹配的药物-靶标结合亲和力预测方法研究
- 批准号:62302456
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
框架核酸多价人工抗体增强靶细胞亲和力用于耐药性肿瘤治疗
- 批准号:32301185
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
抗原非特异性B细胞进入生发中心并实现亲和力成熟的潜力与调控机制
- 批准号:32370941
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
A simulation platform to predict dose and therapeutic window of immunocytokines
预测免疫细胞因子剂量和治疗窗的模拟平台
- 批准号:
10698708 - 财政年份:2023
- 资助金额:
$ 34.85万 - 项目类别:
TNFRSF13B polymorphisms and immunity to transplantation
TNFRSF13B 多态性与移植免疫
- 批准号:
10734879 - 财政年份:2023
- 资助金额:
$ 34.85万 - 项目类别:
Selective Activators of Nrf2 for Neurodegenerative Disease
Nrf2 选择性激活剂治疗神经退行性疾病
- 批准号:
10758091 - 财政年份:2023
- 资助金额:
$ 34.85万 - 项目类别:
CD98hc Brain Shuttles for Delivering Off-the-shelf Neuroprotective Antibodies in Alzheimer's Disease
CD98hc 脑穿梭机为阿尔茨海默病提供现成的神经保护抗体
- 批准号:
10566062 - 财政年份:2023
- 资助金额:
$ 34.85万 - 项目类别:
Modulating Fibrinolysis Dynamics by Leveraging Multivalent Avidity to Control Enzyme Activity
通过利用多价亲和力控制酶活性来调节纤维蛋白溶解动力学
- 批准号:
10635496 - 财政年份:2023
- 资助金额:
$ 34.85万 - 项目类别: